Status:
COMPLETED
Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The Protocol section needs to be updated using the following text "The main goal of the study was to validate the Preference Module of the EARNS-Q and to test the reliability using Treatment Satisfact...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Seasonal allergic rhinitis.
- Nasal allergy symptoms during the spring allergy season.
- Exclusion Criteria:
- Prior use of beclomethasone dipropionate or flunisolide.
- Significant concomitant medical conditions.
- Use of corticosteroids.
- Use of allergy and other identified medications during the study.
- Current tobacco use or tobacco use within the past year.
Exclusion
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2006
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00346775
Start Date
May 1 2006
End Date
June 29 2006
Last Update
January 16 2018
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Fresno, California, United States, 93720
2
GSK Investigational Site
Napa, California, United States, 94558
3
GSK Investigational Site
Roseville, California, United States, 95678
4
GSK Investigational Site
San Francisco, California, United States, 94102